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Introduction: The current use of arterial punctures, when obtaining arterial blood gas and 
acid-base status of patients, are associated with a risk of side effects such as pain and hematoma, 
and a small risk of more severe complications. This analysis investigated the cost-effectiveness 
of a new method, where less painful venous-converted tests are used as an alternative to arte-
rial punctures.
Methods: A cost–utility analysis was conducted from the Danish hospital perspective using a 
Markov model. The model represents the admission of a typical patient suffering from chronic 
obstructive pulmonary disease to the Department of Pulmonary Medicine, Aalborg Hospital. 
Evidence of the effect of the venous-converted tests’ pain reduction was converted into short-
term gain in quality-adjusted life years (QALYs), using the Danish EuroQol-5 Dimension value 
set. A Monte Carlo second order simulation of 10,000 hypothetical patients was conducted for 
a midsized and a small department.
Results: Monte Carlo simulation of the incremental cost-effectiveness ratio (ICER) was domi-
nant for a midsized department, and for a small department the mean was £10,645 per QALY 
gained. The scatter plot of ICERs revealed that at a willingness-to-pay (WTP) of £30,000 per 
QALY gained, the venous conversion method is .95% cost-effective in a midsized department 
and 51% in a small department.
Conclusion: It was concluded that the venous conversion method should be applied to hospitals 
with midsized pulmonary departments, and could be applied to small pulmonary departments 
if the WTP is sufficient.
Keywords: arterial punctures, cost–utility analysis, Markov model, pain, hematoma
Introduction
Measurement of arterial blood gas and acid-base status is a helpful and often  necessary 
tool when assessing the state of the acutely ill patient. Arterial punctures, which are 
considered to be the reference technique for measuring the acid-base status and the 
gaseous content of the blood, are widely performed in intensive care units and in 
emergency and pulmonary medicine departments by specially trained staff. In order to 
monitor the status of patients admitted to departments of pulmonary medicine, arterial 
blood gas and acid-base status must be assessed frequently which requires repeated 
arterial punctures. The use of arterial punctures is associated with a risk of side effects, 
such as pain and hematoma, and a small risk of more severe complications such as 
false aneurysms, ischemia, and neuropathy.1–4
Alternatives to the use of arterial blood have been investigated, including warming 
of the sampling site to arterialize venous blood.5–7 Rees et al have presented a method 
for calculating values of arterial blood from  anaerobically-taken venous samples, 
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 supplemented with pulse oximeter measurements of  arterial 
oxygen saturation (SpO
2
).8 This method mathematically 
transforms peripheral venous values into arterial values by 
simulating the transport of blood back through the tissue. 
The method has been shown to calculate arterial values with 
reasonable precision and as such is not considered to increase 
mortality or initiation of additional treatments. This makes the 
method useful for assessing blood gas and acid-base status 
in the vast majority of patients.9,10 Currently, no studies have 
explored the cost-effectiveness of such a method if applied 
to a pulmonary medicine department.
This study performs a cost–utility analysis (CUA), based 
on a Markov model, investigating whether clinical applica-
tion of the venous conversion method is cost-effective when 
compared to the use of arterial punctures.
Material and methods
A decision analytic model was constructed to estimate the 
incremental cost-effectiveness ratio (ICER) of the venous 
conversion method as an alternative to current practice, when 
used at departments of pulmonary medicine. The study was 
based on patients suffering from chronic obstructive pulmo-
nary disease (COPD) with acute respiratory problems, since 
this group of patients is the recipient of the vast majority 
of arterial punctures performed in pulmonary departments. 
The study was conducted in accordance with international 
guidelines and based on best available evidence.11
The economic evaluation was performed from the Danish 
hospital service’s perspective, using the Department of Pulmo-
nary Medicine at Aalborg Hospital, Denmark, as a reference 
site. The department has 25 beds, of which seven are estimated 
to be occupied with COPD patients with acute respiratory 
problems. Danish hospital statistics shows that the older COPD 
patients, which is the predominant group presenting at Aalborg 
Hospital, have an average stay of 6 days.12 In the department, 
1,958 arterial punctures were performed in 2009, from which 
90% were drawn from COPD patients, making it an average of 
4.1 arterial punctures per patient. All prices are at 2008–2009 
level (value-added tax excluded). Calculations have been made 
in Danish krone (Kr), with values converted to pounds sterling 
(£) using the exchange rate £1 Kr = 8.6376 (May 5th, 2010). 
Costs for the two methods have been calculated using average 
direct costs per patient, however only incremental costs have 
been considered.
Description of the Markov model
The Markov model represents the admission of a typical 
COPD patient to a department of pulmonary medicine, where 
two alternative methods can be used to assess the patient’s 
blood gas and acid-base status – current clinical practice and 
the venous conversion method. For current clinical practice, 
the model assumes a chance of receiving only an arterial 
puncture during each day of admission until the patient is 
well enough to be discharged. When a patient is discharged 
from the hospital no further tests are performed.
The venous conversion method is defined as a combination 
of both venous-converted tests and arterial samples performed 
during the duration of patient admission. This is necessary as 
pulse oximetry values are essential for the venous conversion 
and at very low values of SpO
2
 these may be inaccurate, and 
hence require an arterial sample instead.13–15 It is conserva-
tively appropriate that SpO
2
 values are very low and hence 
inaccurate in 10% of cases. Clinical application of the venous 
conversion method therefore is defined as a mixture of 90% 
venous-converted tests and 10% arterial samples.
For the venous conversion method there exist three 
Markov states, since the patient has a chance of being 
discharged or remaining admitted with a chance of receiv-
ing either an arterial puncture or a venous-converted test 
(Figure 1). The venous-converted test may replace the vast 
majority of arterial punctures, which was interpreted as 90% 
(standard deviation [SD] ± 3%) of all blood gas analyses 
being performed, whereas the rest are performed as arterial 
punctures.9,10 This mixture of venous-converted tests and arte-
rial punctures is defined as the venous conversion method.
The model was constructed with a total of 11 cycles, 
with each cycle representing 1 day of admission, and the 
patients were given a 100% probability of being discharged 
after 10 days. The model was calibrated to reflect current 
practice at Aalborg Hospital so that an average patient was 
admitted 6 days and received 4.1 blood gas analyses. The 
model assumes a chance of receiving a test each day while 
admitted. The probability of receiving a puncture each day 
during admission was set to be the greatest during the first 
days of admission and to decrease with prolonged admission, 
as in accordance with clinical practice. The Markov model 
was built in TreeAge Pro Healthcare module 2009 (TreeAge 
Software Inc, Williamstown, MA).
Model input
In the model, different costs are associated with the current 
method and the venous conversion method. The venous con-
version method requires initial investment in software and 
education before implementation, and the costs are therefore 
split into initial and incremental costs. It is expected that 
nurses can perform all venous-converted tests after a short 
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instruction, and the estimated cost of teaching nurses can 
be seen in Table 1. Since venous-converted tests are not yet 
approved for health care use, the price of a product license is 
an estimate. Other product licenses for the blood gas analyzer 
at Aalborg Hospital are priced in the range £1,700–£4,600, 
and the price of the license for the venous conversion method 
is therefore given an intentionally conservative estimate of 
£4,600 (SD ± £1,500). To account for the rapid evolution of 
technology, the cost of the product license is discounted using 
a 3% interest for 5 years. In the model it is assumed that a 
Current method
Discharged
Discharged without further tests
Discharged without further tests
Discharged
Discharged
Discharged
Admitted
Admitted
Admitted
Admitted
Admitted with chance of
venous-converted test
Admitted with chance of
arterial puncture
Admitted with chance of
arterial puncture
Admitted
Venous conversion method
Assessment of arterial blood gas
and acid-base status in departments
of pulmonary medicine
M
M
Figure 1 Markov model of admission to pulmonary department.
Table 1 Model input for cost-effect and department assumptions
Costs
Variable EV ±SD Ref.
Initial costs for venous conversion method
Education of nurses in venous conversion method (£) 770 400 Expert opinion
Product license to blood gas analyzer (£) 4,600 1500 Expert opinion
Incremental costs
Time use for arterial punctures (seconds)
 – Doctor 360 + 134 15 Expert opinion
 – nurse 60 + 134 15 +3
 – Biomedical laboratory technicians 120 + 134 15
Time use for venous-converted tests (seconds) Expert opinion
 – nurse 60 + 134 15 +3
Annual cost of personnel (£)
 – Doctors 69,150 21,380 hD
 – nurses 41,520 5,810 hD
 – Laboratory technicians 42,880 4,790 hD
Complications per arterial puncture (£) 0.16 0.05 2,16–18
Materials for arterial punctures (£) 0.85 0.08 hD
Materials for venous-converted tests (£) 0.56 0.04 hD
Probability for extra use of materials
 – Arterial punctures 0.1 0.025 2,3,18
 – Venous punctures 0.05 0.01 3
Outcome assumptions
Effect of a venous-converted test (QALY) 0.00000035 0.00000018 3,21 + expert
Effect of an arterial puncture (QALY) 0 0 opinion
Assumptions for midsized department
Arterial punctures performed* 1958 100 hD
Blood gas analysis ordered 1789 100 Expert opinion
number of patients per year 426 50 hD
Assumptions for small department
Arterial punctures performed* 818 50 Expert opinion
Blood gas analysis ordered 748 50 Expert opinion
number of patients per year 178 25 Expert opinion
Note: *includes tests redone.
Abbreviations: EV, expected value; sD, standard deviation; Ref, reference; hD, hospital database; QALY, quality-adjusted life year.
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blood gas analyzer, which is compatible with the required 
software for the venous conversion method, is already pres-
ent at the department. The incremental costs for the venous 
conversion method and the current method, ie, the costs 
assigned each performed test, are given in Table 1.
The time spent by each group of health care professionals 
performing arterial punctures is estimated in correspondence 
with the localization of each group at Aalborg Hospital. It is 
assumed that nurses are situated in the department, whereas 
doctors and laboratory technicians are called upon whenever 
an arterial blood sample is required. In Table 1 this is shown 
with two time estimates for each group, one for walking 
distance and one for obtaining the sample, the latter estimate 
being the same for all groups.3 Whenever a doctor performs 
an arterial puncture, the model assumes that a nurse is also 
present. The model assumes that 8% of arterial punctures 
are performed by doctors, 59% by laboratory technicians, 
and 33% by nurses. Complications from performing arte-
rial punctures, which require additional treatment, were 
considered an additional cost.16–18 However, the cost for 
severe complications has not been included in the analysis, 
as the incidence of severe complications occurring at  Danish 
Hospitals was considered extremely low. By excluding 
severe complications from the study, the analysis becomes 
conservative. In addition, the possible gain in quality of 
life (QOL) from avoiding complications was not assessed. 
Furthermore, severe complications are poorly reported in the 
literature.4,19,20 Current prices paid by Aalborg Hospital were 
used as the expected values for the cost of materials for both 
the current and venous conversion method. All inputs used 
for the model are given in Table 1.
The CUA uses an estimation of quality-adjusted life 
years (QALYs) gained as outcome measurement, estimates 
of which are given in Table 1. To obtain these estimates it 
was necessary to evaluate the pain inflicted when performing 
arterial punctures compared to venous punctures. Giner et al 
have compared the pain perceived by patients during arterial 
punctures or venous punctures on a visual analog scale (VAS) 
of pain.3 The mean level of pain for arterial punctures was 
shown to be slight to moderate (3.01 ± 1.94 cm), whereas 
only a slight pain was experienced for venous punctures 
(1.80 ± 1.10 cm). In order to transform the incremental pain 
intensity during the two types of punctures into a change 
in QOL for the CUA, the Danish EuroQol-5 Dimension 
(EQ-5D) health state evaluation was used. When answering 
the EQ-5D questionnaire regarding pain, if answering to 
have moderate pain instead of no pain, the QOL is reduced 
by 0.062 regardless of all other answers.21 The assumption 
for the CUA is that arterial punctures cause the patient to go 
from having no pain to having moderate pain when receiving 
the test, and thereby reducing their QOL by 0.062. To estimate 
the gain in QALYs for the CUA it is assumed that patients 
receiving a venous-converted test instead of an arterial 
puncture will have a gain in QOL of 0.062 for 3 minutes 
corresponding to 0.00000035 QALY (SD ± 0.00000018 
QALY), as given in Table 1.
The Department of Pulmonary Medicine at Aalborg Hospi-
tal performs approximately 2,000 arterial punctures each year, 
and is therefore classified here as a midsized department. How-
ever, not all hospitals have such large departments of pulmonary 
medicine. Analysis was therefore also performed to calculate 
the costs and benefits for a smaller department performing 
approximately 800 per year. When performing arterial punc-
tures some samples become contaminated with venous blood, 
resulting in an additional puncture being performed. Through 
expert opinions it was estimated that 1/10 to 1/20 arterial 
punctures must be redone. This results in a difference between 
performed tests and ordered tests, as seen in Table 1.
sensitivity analysis
A probabilistic sensitivity analysis (second order Monte 
Carlo simulation) was conducted using a cohort of 10,000 
trial simulations for both a midsized department and a small 
department. Each parameter in the model was given a reason-
able range (Table 1) with a distribution function, which then 
was randomly drawn using the stochastic process.22 All prob-
abilities were given beta distributions, and time consumption, 
costs, and QALY estimates were given gamma distributions. 
The results obtained from the Monte Carlo simulation were 
illustrated in a scatter plot distribution of ICER by plotting 
incremental cost along the y-axis and incremental effect along 
the x-axis. An acceptability curve was applied to the ICER 
distribution scatter plot to identify which strategy would be 
most cost-effective at the willingness-to-pay (WTP) thresh-
olds of £30,000 per QALY gained.23 A dominant strategy 
was defined as having a lower incremental cost and a higher 
incremental effect. Cost-effectiveness acceptability curves 
(CEACs) were drawn in order to identify which method 
would be most cost-effective at various WTP. The CEACs 
show the probability that a given method will be cost-effective 
when the WTP is increased along the x-axis.22 A CEAC is 
based on the assumption that hospitals may use different 
WTP limits and the CEAC therefore offers information on 
the cost-effectiveness of methods when altering the WTP.
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Results
Table 2 gives the results of the Monte Carlo simulations 
for the different department types. An estimated £3.10 
(SD ± 1.54) could be saved per admission in a midsized 
department, whereas in a small department there was an 
additional cost of £0.01 (SD ± 2.40) per admission.
Both showed an incremental effect of 0.0000012 QALY 
(SD ± 0.0000006) per admission. From the Monte Carlo 
simulations a scatter plot of ICERs was made for both a 
midsized department (Figure 2A) and a small department 
(Figure 2B).
A one-way sensitivity analysis revealed that the number 
of performed arterial punctures was the parameter with great-
est influence on results (data not shown).
The scatter plot text report reveals that at a WTP of £30,000 
per QALY gained, the venous conversion method is .95% 
cost-effective in a midsized department and 51% in a small 
department. Monte Carlo simulation of the ICER for a small 
department had a mean of £10,645 per QALY gained. A CEAC 
was plotted to illustrate the venous conversion method’s prob-
ability of being cost-effective at various WTP (Figure 3).
Figure 3 illustrates the probability of the venous conver-
sion method being cost-effective in small departments. As 
seen in Figure 3, it is uncertain whether the venous conver-
sion method is cost-effective in small departments, which is 
particularly due to the fewer samples performed.
The results therefore clearly show the advantage of large 
scale use of the venous conversion method.
Discussion
The results show that the venous conversion method is a 
cost-effective way to assess patient blood gas and acid-
base status in pulmonary departments if the ward is of a 
sufficient size. The CUA performed in this study showed 
Table 2 Main results of probabilistic sensitivity analysis
Monte Carlo 
simulation  
results for:
Midsized  
department
Small  
department
incremental cost  
per admission:
-£3.10 (sD ± 1.54) £0.01 (sD ± 2.40)
incremental effect  
per admission:
0.0000012 QALY 0.0000012 QALY
(sD ± 0.0000006) (sD ± 0.0000006)
iCER Dominant £10,645
Percentage cost-effective  
at a WTP of £30,000  
per QALY gained
.95% 51%
Abbreviations: sD, standard deviation; iCER incremental cost-effectiveness ratio; 
WTP, willingness-to-pay; QALY, quality adjusted life year.
that the venous conversion method is expected to be a 
dominant strategy in a midsized department, and is .95% 
cost-effective at a WTP of £30,000 per QALY gained com-
pared to 51% cost-effective in a small department. In small 
departments, fewer arterial punctures are performed each 
year causing the venous conversion method to be less likely 
to be cost-effective at a WTP of £30,000. The estimates for 
a small department in this study can therefore be viewed 
as a lower limit for the number of samples performed each 
year, because in smaller departments the venous conversion 
method would not be the most cost-effective option. The 
venous conversion method therefore holds great potential 
for larger departments performing numerous arterial punc-
tures annually. The method may also have potential in other 
departments where arterial blood sampling is performed via 
needle puncture, for example, in departments of emergency 
medicine where arterial blood gas measurement is common 
in patients presenting with respiratory complications and 
where venous blood is sampled in many patients but sel-
dom used for blood gas analysis. Indeed, by synchronizing 
venous blood gas and other routinely taken venous blood 
samples, it may be possible to reduce the number of venous 
punctures required, thereby increasing the cost-effectiveness 
of the method.
Several limitations exist in this analysis. A blood gas 
analyzer which supports the software is a requirement, and 
purchase of new equipment solely to support the method is 
unlikely to be cost effective. The study estimated an increase 
in QOL of 0.062 for 3 minutes per venous-converted test to 
quantify the less painful venous puncture when compared 
to arterial. The use of QALYs as a measure in acute con-
ditions has been questioned;24 however QALYs are often 
considered the main health outcome measure when investi-
gating the cost-effectiveness of new interventions.23 Clearly, 
when performing arterial punctures the patient is exposed 
to pain and thereby the QOL is temporarily reduced, even 
though completion of the test only takes a few minutes. 
Only the change in QOL due to pain has been accounted 
for in this study; however it should not be underestimated 
that other factors may affect QOL. COPD patients often 
receive multiple tests, and the awareness of forthcoming 
pain may also lead to anxiety and general discomfort for 
these patients, which may lead to a further lowering of 
QOL. In addition, by avoiding all types of complications 
from arterial punctures, the QOL for some COPD patients 
will be increased further. This provides further proof that 
the QOL changes during arterial sampling, and thereby a 
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Figure 2 incremental cost-effectiveness ratio scatterplots for midsized and small departments.
QALY gain is present, regardless of the uncertainty in the 
measurement of the gain in QOL.
Assumptions made as part of the analysis have intention-
ally been conservative, and there may be additional cost–
benefit from use of the venous conversion method. The initial 
cost of the license, assumed to be £4,600, is an estimate in 
the higher range of the usual prices for software updates 
to medical devices. Arterial punctures also include minor 
risk of severe complications such as ischemia, neuropathy, 
and false aneurysms.4,19,20 Quantification of the incidence 
of severe complications is poorly reported in the literature 
and it was therefore excluded in the analysis. Including it 
would provide additional cost–benefit for the venous con-
version method.
Conclusion
It is concluded that the venous conversion method should be 
applied to hospitals with midsized pulmonary departments, 
and could be applied to small pulmonary departments if the 
WTP is sufficient.
Acknowledgments
We thank Mikkel Troels Rasmussen and Rasmus Hogreffe 
Sørensen, who assisted in data collection.
Disclosure
Stephen E Rees is a board member and shareholder of OBI 
ApS, who hold a patent on the venous to arterial conversion 
method.
References
1. Berger A. Brachial artery puncture: the need for caution. J Fam Pract. 
1989;28(6):720–721.
2. Gillies ID, Morgan M, Sykes MK, Brown AE, Jones NO. The nature and 
incidence of complications of peripheral arterial puncture. Anaesthesia. 
1979;34(5):506–509.
3. Giner J, Casan P, Belda J, Gonzalez M, Miralda RM, Sanchis J. Pain 
during arterial puncture. Chest. 1996;110(6):1443–1445.
4. McCready RA, Hyde GL, Bivins BA, Hagihara PF. Brachial artery  puncture: 
a definite risk to the hand. South Med J. 1984;77(6):786–789.
5. Pitkin AD, Roberts CM, Wedzicha JA. Arterialised earlobe blood gas 
analysis: an underused technique. Thorax. 1994;49(4):364–366.
ClinicoEconomics and Outcomes Research
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journal
ClinicoEconomics & Outcomes Research is an international, peer-
reviewed open-access journal focusing on Health Technology Assess-
ment, Pharmacoeconomics and Outcomes Research in the areas of 
diagnosis, medical devices, and clinical, surgical and pharmacological 
intervention. The economic impact of health policy and health systems 
organization also constitute important areas of coverage. The manu-
script management system is completely online and includes a very 
quick and fair peer-review system, which is all easy to use. Visit 
http://www.dovepress.com/testimonials.php to read real quotes from 
published authors.
ClinicoEconomics and Outcomes Research 2011:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
7
Cost-effectiveness of venous-converted tests
 6. Zavorsky GS, Cao J, Mayo NE, Gabbay R, Murias JM. Arterial  versus 
capillary blood gases: a meta-analysis. Respir Physiol Neurobiol. 
2007;155(3):268–279.
 7. Zello GA, Smith JM, Pencharz PB, Ball RO. Development of a heating 
device for sampling arterialized venous blood from a hand vein. Ann 
Clin Biochem. 1990;27(Pt 4):366–372.
 8. Rees SE, Toftegaard M, Andreassen S. A method for calculation 
of arterial acid-base and blood gas status from measurements in the 
peripheral venous blood. Comput Methods Programs Biomed. 2006; 
81(1):18–25.
 9. Rees SE, Hansen A, Toftegaard M, Pedersen J, Kristiensen SR, 
Harving H. Converting venous acid-base and oxygen status to arterial 
in patients with lung disease. Eur Respir J. 2009;33(5):1141–1147.
 10. Toftegaard M, Rees SE, Andreassen S. Evaluation of a method for 
converting venous values of acid-base and oxygenation status to arterial 
values. Emerg Med J. 2009;26(4):268–272.
 11. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. 
Methods for the Economic Evaluation of Health Care Programmes. 
3rd ed. Oxford, UK: Oxford University Press; 2005.
 12. National Board of Health. Visual DkDRG. 2010 Feb 2. Available from: 
http://visualdkdrg.sst.dk/2007/. Accessed Aug 30 2010.
 13. Kolb JC, Farran P, Norris SR, Smith D, Mester J. Validation of pulse 
oximetry during progressive normobaric hypoxia utilizing a portable 
chamber. Can J Appl Physiol. 2004;29(1):3–15.
 14. van de Louw A, Cracco C, Cerf C, et al. Accuracy of pulse oximetry in 
the intensive care unit. Intensive Care Med. 2001;27(10):1606–1613.
 15. Wouters PF, Gehring H, Meyfroidt G, et al. Accuracy of pulse 
 oximeters: the European multi-center trial. Anesth Analg. 2008; 
94 Suppl 1:S13–S16.
 16. Ankjaer-Jensen A, Rosling P, Bilde L. Variable prospective financing 
in the Danish hospital sector and the development of a Danish case-mix 
system. Health Care Manag Sci. 2006;9(3):259–268.
 17. National Board of Health. DAGS rates for outpatient clinics (2009). 
2010 Jan 11. Available from: http://www.sum.dk/Sundhed/DRG-
systemet/Takster/2009.aspx Accessed Aug 30 2010.
 18. Okeson GC, Wulbrecht PH. The safety of brachial artery puncture for 
arterial blood sampling. Chest. 1998;114(3):748–751.
 19. Luce EA, Futrell JW, Wilgis EF, Hoopes JE. Compression  neuropathy 
following brachial arterial puncture in anticoagulated patients. 
J Trauma. 1976;16(9):717–721.
 20. Matsagas MI, Mitsis M, Rigopoulos C, et al. A large radial 
artery false aneurysm after repeated arterial punctures, causing 
compartment syndrome of the forearm. Intensive Care Med. 2003; 
29(6):1032.
 21. Wittrup-Jensen KU, Lauridsen J, Gudex C, Pedersen KM. Generation 
of a Danish TTO value set for EQ-5D health states. Scand J Public 
Health. 2009;37(5):459–466.
 22. Fox-Rushby J, Cairns J, editors. Economic Evaluation. Maidenhead, 
UK: Open University Press; 2005.
 23. National Institute for Health and Clinical Excellence. Social value 
judgements: principles for the development of NICE guidance. 
2010 Feb 11. Available from: http://www.nice.org.uk/media/C18/30/ 
SVJ2PUBLICATION2008.pdf. Accessed Aug 30 2010.
 24. Bala MV, Zarkin GA. Are QALYs an appropriate measure for valuing 
morbidity in acute diseases? Health Econ. 2000;9(2):177–180.
